Lupron vs Fensolvi vs Supprelin for Precocious Puberty

All four medications used for central precocious puberty in the US — Lupron Depot-Ped, Fensolvi, Triptodur, and Supprelin LA — are GnRH agonists that pause puberty by the same mechanism. What differs is the active ingredient, how it is given, and how often. Choice usually comes down to schedule, route, and coverage rather than effectiveness.

Families often arrive at this comparison assuming one product is stronger or safer than the others. That is not the shape of the decision. These are all long-established treatments that suppress puberty effectively. The real question is which delivery schedule fits your child and your family.

Note that Triptodur belongs in this comparison even though it is less often searched by name. It is a genuine fourth option and may be what your child is already on.

How they compare

All four suppress LH, FSH, and sex hormone production. All four are reversible. None of them are permanent.

What they have in common

Central precocious puberty happens when the brain activates the reproductive axis years early. GnRH agonists work by continuously occupying pituitary receptors so they stop responding to the brain's pulsed signal. LH and FSH fall, and puberty pauses.

Because the mechanism is identical across products, so is most of what follows:

• The goals. Preserving adult height potential, and giving a young child developmental time that matches her age.
• The monitoring. Periodic bone age films, growth tracking, exam, and hormone levels to confirm suppression.
• The reversibility. Puberty resumes after treatment stops, typically within months.
• The side effect profile. Injection site reactions are the most common issue and vary somewhat by route. Headaches, mood changes, and hot flashes are reported. Sterile abscess at the injection site is uncommon but recognized.
• The fertility evidence. Long-term follow-up in children treated for central precocious puberty has not shown impaired adult fertility. We cover that literature in detail in does Lupron for precocious puberty affect fertility.

What actually drives the choice

Injection frequency and family logistics. This is usually the biggest factor. A monthly injection means up to twelve visits a year, which for a family traveling to see a specialist is a substantial burden on a child's school schedule and a parent's work schedule. Six-month dosing reduces that to two.

Whether a procedure is acceptable. Supprelin LA requires a small in-office procedure to place the implant under the skin of the upper arm, and another to remove or replace it at twelve months. Some families much prefer one annual procedure to repeated injections. Others would rather avoid a procedure entirely. Both are reasonable, and this is genuinely a preference question.

Route. Fensolvi is subcutaneous; Lupron Depot-Ped and Triptodur are intramuscular. For a needle-anxious child, this can matter.

Duration of treatment expected. A child expected to be treated for several years weighs the annual-implant math differently than one expected to be treated for a shorter period.

Coverage and formulary. Plans have preferred products, and prior authorization criteria differ. This is frequently the practical constraint, and it is worth checking before a family becomes attached to a particular option.

Adherence. A longer interval means fewer chances to fall behind schedule. For families with complicated logistics, this is a clinical consideration and not just a convenience one.

Are they used in the same children?

Broadly yes. All four are approved for central precocious puberty, and there is no subgroup of children for whom only one will work. A child can be started on one and switched to another if the schedule proves impractical, if there are site reactions, or if coverage changes.

There are some age and weight considerations in the labeling that a physician will factor in, and dosing for the monthly Lupron formulation is weight-based while the longer-interval products generally are not. Those details are worked out in the visit, not chosen from a website.

Note that none of these treat peripheral precocious puberty, where sex hormones are produced outside the normal brain-driven pathway. That condition does not respond to GnRH agonists and is managed differently, which is one reason confirming the diagnosis matters before choosing any product.

Questions worth asking your endocrinologist

• Why this product for my child specifically?
• How many visits per year will this mean for us?
• What is the plan for confirming that puberty is actually suppressed?
• How often will bone age be repeated?
• What is the plan for when we stop, and what determines that timing?
• If the schedule turns out not to work for us, can we switch?
• What does my plan cover, and what will this cost?

The stopping decision deserves particular attention. Adult height outcomes are best when treatment is withdrawn at an appropriate bone age rather than a particular birthday, which is why the periodic hand X-ray continues throughout.

When to see a pediatric endocrinologist

• Breast development before age 8 in a girl, or testicular enlargement before age 9 in a boy
• A rapid growth acceleration alongside early pubertal signs
• A bone age reported as significantly advanced
• Your child has been recommended for a GnRH agonist and you want a second opinion
• Your child is already on treatment and the schedule is not working for your family
• You are unsure whether it is time to stop

Frequently asked questions

How do Lupron, Fensolvi, and Supprelin differ?

They use different active ingredients and delivery methods. Lupron Depot-Ped is leuprolide given as an intramuscular injection. Fensolvi is leuprolide given subcutaneously. Supprelin LA is histrelin delivered by an implant placed under the skin of the upper arm. Triptodur, a fourth option, is triptorelin given intramuscularly. All work by the same mechanism.

How often is each one given?

Lupron Depot-Ped is given monthly or every three months, depending on the formulation. Fensolvi is given every six months. Triptodur is given every 24 weeks. Supprelin LA is an implant that is replaced every twelve months. Dosing schedule is one of the main reasons families choose one over another.

Are they used in the same children?

Broadly yes. All four are approved for central precocious puberty, and there is no group of children for whom only one option works. A child can be switched between products if the schedule is impractical, if there are injection site reactions, or if insurance coverage changes. None of them treat peripheral precocious puberty.

Do these medications affect fertility?

Long-term follow-up studies of children treated for central precocious puberty have not found reduced adult fertility. Research following women more than a decade after treatment showed normal reproductive function, and studies in men found no differences in gonadal function. The effect on puberty is temporary and reverses after treatment stops.

Medically reviewed by

Payal Patel, MD — Board-certified pediatric endocrinologist at LIFE Pediatric Endocrinology, focused on growth and puberty care. Full profile →

Toni Kim, MD — Founder, LIFE Pediatric Endocrinology. Board-certified pediatric endocrinologist specializing in growth and puberty disorders. Full profile →

Talk with a pediatric endocrinologist

Choosing among these products is a conversation about your child and your family's logistics, not a ranking. It deserves more than a few minutes.

LIFE Pediatric Endocrinology sees families across the country by telemedicine, and in person at our offices in Austin, Sandy Springs, Beverly Hills, Newport Beach, and Brentwood. Request a consultation →

Medical disclaimer

This article is for general educational purposes and does not constitute medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a qualified healthcare professional, and reading it does not create a physician-patient relationship. Every child is different. Do not start, stop, or change any medication based on this article. Talk with your child's pediatrician or a pediatric endocrinologist about your child's specific situation. If your child has a medical emergency, call 911 or go to the nearest emergency department.

Sources

• Prescribing information: Lupron Depot-Ped (AbbVie), Fensolvi (Tolmar), Triptodur (Azurity), Supprelin LA (Endo Pharmaceuticals)
• Popovic J, et al. Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States. Front Pediatr. 2022;10:968485.
• Ergun-Longmire B, et al. A narrative review: treatment outcomes of central precocious puberty. Pediatric Medicine. 2022.
• Pediatric Endocrine Society — clinical guidance on central precocious puberty